剖宫产瘢痕缺损(isthmocele)的最佳管理:宫腔镜、腹腔镜或联合入路
本系统综述检索了PubMed/Medline、Embase和Cochrane数据库近20年关于isthmocele修补的研究,最终纳入31篇文献(宫腔镜21篇,腹腔镜或联合13篇)。结果显示,有症状者修补有效;残余肌层厚度>2~3 mm时宫腔镜重塑是首选,<2~3 mm时腹腔镜联合宫腔镜效果相似,但现有数据尚无法确定确切截断值。
要点
- 有症状的isthmocele患者,修补是合理选择。
- 残余肌层厚度>2~3 mm者,宫腔镜重塑为首选。
- 残余肌层厚度<2~3 mm者,腹腔镜联合宫腔镜效果相似。
核心结论
- 有症状的isthmocele患者修补是有效选择,但宫腔镜与腹腔镜的选择截断值尚无法从现有数据得出。
研究设计与样本
- 系统综述,检索PubMed/Medline、Embase和Cochrane数据库近20年文献,纳入31篇研究(宫腔镜21篇,腹腔镜或联合13篇,其中4篇同时评估两种方式)。
主要发现
- 宫腔镜重塑改善异常子宫出血的有效率为60%~100%,腹腔镜为78%~94%。
- 宫腔镜和腹腔镜治疗后,有生育意愿者妊娠率分别为46%~100%和37.5%~90%。
- 疼痛和痛经似乎不常见,但抱怨疼痛或痛经者中66%~100%有明显改善至完全缓解。
关键数值与推荐
- 残余肌层厚度>2~3 mm时,宫腔镜重塑是首选方式。
- 残余肌层厚度<2~3 mm时,腹腔镜联合宫腔镜引导下修补显示相似结果。
- 基于常见实践和专家意见推荐2.5 mm作为截断值,但宫腔镜与腹腔镜治疗间未显示显著性差异。
临床怎么用
- 对无症状isthmocele患者通常无需干预;有症状者可根据残余肌层厚度选择宫腔镜或腹腔镜修补。
局限性
- 现有数据有限,无法得出宫腔镜与腹腔镜选择的确切截断值。
- 评估疼痛改善的研究样本量均少于10例。
- 继发性不孕并非所有研究都进行了评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conduct a systematic review of the literature on the hysteroscopic and laparoscopic repair of isthmocele. DATA SOURCES: A thorough search of the PubMed/Medline, Embase, and Cochrane databases was performed. (PROSPERO registration number CRD42020190668). METHODS OF STUDY SELECTION: Studies from the last 20 years that addressed isthmocele repair were collected. Both authors screened for study eligibility and extracted data. All prospective and retrospective studies of more than 10 women were included. TABULATION, INTEGRATION, AND RESULTS: The initial search identified 666 articles (Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart) (see Supplemental Fig.). We excluded duplicates, case reports, reviews, video articles, and technique articles. We also excluded studies describing only laparotomy or vaginal repair as these were not in the scope of this review. A total of 31 articles met the inclusion criteria, 21 for hysteroscopic resection and 13 for laparoscopic or combined repair (4 articles tested both modalities and appear in both Tables 1 and 2).For abnormal uterine bleeding, hysteroscopic remodeling relived symptoms in 60% to 100% of cases and laparoscopy in 78% to 94%. Secondary infertility was not evaluated in all studies. After hysteroscopic and laparoscopic treatment, 46% to 100% and 37.5% to 90% of those who wished to conceive became pregnant, after the procedure, respectively. Pain and dysmenorrhea seem to be uncommon. All studies that tested improvement of pain had fewer than 10 women. However, between 66% and 100% of women who complain of pain or dysmenorrhea will note a marked improvement to full resolution. CONCLUSION: Patients with an isthmocele or cesarean scar defect are usually asymptomatic. For symptomatic women, a repair is a valid option. For those with residual myometrial thickness >2 to 3 mm, hysteroscopic remodeling is the modality of choice with an improvement in abnormal uterine bleeding, secondary infertility, and pain. Women with a residual myometrial thickness <2- to 3-mm laparoscopic repair with simultaneous hysteroscopic guidance show similar results. Because available data are limited, no cutoff for the correct choice between hysteroscopy and laparoscopy can be concluded. We recommend 2.5 mm as the cutoff value based on common practice and expert opinion, although no significance between hysteroscopic and laparoscopic treatment was shown.
引用
- Mashiach R, Burke YZ. Optimal Isthmocele Management: Hysteroscopic, Laparoscopic, or Combination. J Minim Invasive Gynecol. 2020. PMID: 33152531. doi:10.1016/j.jmig.2020.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。